Similar articles

• New lessons from old drugs: amantadine and Parkinson's disease.

  Goetz CG. Goetz CG. Neurology. 1998 May;50(5):1211-2. doi: 10.1212/wnl.50.5.1211. Neurology. 1998. PMID: 9595964 Clinical Trial. No abstract available.
• [Amantadine in the therapy of Parkinson syndromes].

  Pfaff G. Pfaff G. Med Klin. 1980 Oct 24;75(22):792-4. Med Klin. 1980. PMID: 7453628 German. No abstract available.
• [Use of amantadine in parkinsonism].

  Crudeli R, Candia O. Crudeli R, et al. Minerva Med. 1971 Oct 31;62(82):3963-4. Minerva Med. 1971. PMID: 5125053 Italian. No abstract available.
• Amantadine: the journey from fighting flu to treating Parkinson disease.

  Hubsher G, Haider M, Okun MS. Hubsher G, et al. Neurology. 2012 Apr 3;78(14):1096-9. doi: 10.1212/WNL.0b013e31824e8f0d. Neurology. 2012. PMID: 22474298 Review.
• Meta-analysis of amantadine efficacy for improving preclinical research reliability.

  Stanley P, Pioli EY, Kozak R, Popiolek M, Bezard E. Stanley P, et al. Mov Disord. 2018 Oct;33(10):1555-1557. doi: 10.1002/mds.27486. Epub 2018 Oct 4. Mov Disord. 2018. PMID: 30288778 No abstract available.